Abstract
Introduction
T he operating environment is a highly vulnerable surgical space where each and every patient is going through medical jeopardy. The patients undergoing the surgical regimen are at the advanced stage of their respective ailments. The initial step of the surgical procedure is the drug interventions that are substantially invasive with dynamic and uncertain physiological responses. The intricacy level with respect to cognitive and task-oriented demands, in the surgical suite, results in influential and unrelenting ambiance, which may aggravate the effects of minute human errors and negligence. [1] Surgical process and safety are impacted by various factors such as clinical competence, attributes of the surgical surroundings, surgical workflow, teamwork, and organizational structures. These factors influence each other and any change or malfunction affects the entire system.
Coronary artery bypass grafting (CABG) surgery is used to treat and improve the blood flow into the heart. This coronary heart disease is caused by the accumulation of substance called plaque inside the arteries. This plaque may be made of cholesterol, fat found in the blood. [2] The build-up plaque in the walls of arteries causes narrowing which reduces the blood flow into the heart, resulting in heart attack, chest pain, or discomfort. During the surgery, the plagued artery is bypassed or grafted to the healthy artery and this provides a new passage for oxygen-rich blood to flow through the heart muscles. The real-time physiological variables and their respective drug infusion rate were obtained where the administration of drug was carried out by an anesthetist manually using syringe pump. The physiological variables obtained during CABG were aortic pressure and cardiac output (CO) with administration of cardiac drugs, such as noradrenaline which acted as vasoconstrictor and nitroglycerine which acted as vasodilator. [3] The maximum allowable limit for noradrenaline is 0.01-3 µg/kg and for nitroglycerine is 0.01-1.5 µg/kg in clinical practice.
Materials and Methods

Mathematical modeling Cardiovascular modeling
The physiological variable such as aortic pressure from which the mean arterial pressure (MAP) is manipulated and CO is controlled using the controller designed by regulating the infusion rate of cardiac drugs. [4] The controller design is based on the mathematical model of the process involved. The mathematical model consists of cardiovascular system with baroreflex mechanism combined with drug modeling based on pharmacokinetics and pharmacodynamics. [5] Since these drugs are used to regulate the hemodynamics of the heart, the cardiovascular model is initially derived by considering four compartments, namely left heart, systemic circulation, right heart, and pulmonary circulation. [6] The circulatory compartments are partitioned into three arterial and two ventricular sections. When the left ventricular pressure exceeds the systemic aortic pressure, the aortic valve opens and the blood enters into systemic circulation through peripheral systemic resistance. [7] dQ dt L P P Systemic circulatory arterial section 1 
Where Q rv is right ventricular flow rate L rv is inertial vessel properties of right ventricle P rv is right ventricular pressure P ap is aortic pulmonary pressure V rv is right ventricular volume E rv is elastance of right ventricle V drv is right ventricular volume at zero pressure R pul is pulmonary resistance P p1 is pressure at pulmonary arterial section 1.
Pulmonary circulatory arterial section 1
Where Q p1 is the flow rate of pulmonary section 1 R p1 , R p2 , R p3 are the viscosity of pulmonary section 1, 2, and 3 C p1 , C p2 , C p3 are the elastic properties of pulmonary sections 1, 2, and 3 L p1 is the inertial vessel properties of pulmonary section 1 P p2 , P p3 are the pressure at pulmonary sections 2 and 3 V p1 , V p2 , V p3 are the volume of pulmonary sections 1, 2, and 3 V unp1 is the volume of pulmonary section 1 at zero pressure V unp3 is the volume of pulmonary section 3 at zero pressure.
Pulmonary circulatory venous section 1 
Baroreceptor modeling
Baroreceptor model acts as the feedback system which helps in short-term regulation of blood pressure.
Baroreceptor is stretch receptor located in the walls of the blood vessels, the most accessible of which are located in the carotid sinus and in the aortic arch. [8] Carotid sinus baroreceptor is located in the distinctive part of the two common carotid sinus arteries. Aortic arch baroreceptor, on the other hand, is located in the walls of the aortic arch. The aortic arch and the carotid sinus receptors are believed to be functionally same, expect that the aortic arch receptors operate at a higher pressure level. [9] The baroreceptor modeled here is concentrated on the carotid sinus which has nerve ending and responds to deformation in the walls of the blood vessels.
The nerve activity evolves from two components, a pressure-mechanical and mechanical-electrical component. The nerve activity from the carotid sinus receptor is called firing rates. The baroreceptor acts immediately to deformations in the blood vessel walls by a pressure-mechanical mechanism. The mechanical-electrical component generates the baroreceptor firing rate by the mechanical-electrical mechanism inbuilt in the receptor. [10] The cardio-inhibitory center and vasomotor center of the central nervous system generates sympathetic nerve activity. The efferent pathway transmits the nerve activity to the cardiovascular model. The input function to the baroreceptor model is expressed as:
Where MAP nom is the nominal value of MAP and α is the constant.
The parameters that are influenced by autonomic reflexes are modeled in such a way that it provides continuous control action to regulate the MAP as shown. 
Pharmacokinetic-pharmacodynamic modeling
The pharmacokinetics and pharmacodynamics of the cardiac drugs such as noradrenaline and nitroglycerine are studied by deriving their volume and drug mass concentration equation which is intervened into the blood and flows into cardiovascular system through circulation process. [11] The flow relationship in four compartments are modeled as:
Where x represents the compartment being considered, Q x − is the input flow from previous compartment and Q x + is the output flow from the next compartment.
The amount of drug entering into each compartment is modeled as- Since the system derived is a multi-input-multi-output system, the maximum influence of cardiac drugs on control variables is to be determined. This is done using relative gain array (RGA) analysis. RGA uses the steady gain of the process to calculate the drug interactions using the expression 
Bacterial foraging-oriented particle swarm optimization
Optimization techniques are involved in process with large complexity and nonlinearity to estimate the optimal values to control the process. [12] [13] [14] [15] In this study, the proportional-integral (PI) controller tuning parameters are determined using bacterial foraging-oriented particle swarm optimization (BFOA-PSO). The combination of bacterial foraging and particle swarm techniques are implemented here. [16] The BFOA and PSO algorithms are combined to utilize the ability of PSO algorithm for social information trade-off and ability of BFOA to determine new solution using elimination and dispersal stage. The bacterial foraging algorithm consists of four stages -chemotaxis, swarming, reproduction, and elimination-dispersal. [17] The MATLAB coding for BFOA-PSO algorithm is as follows: %% Tuning of PI controller using bacterial foraging oriented particle swarm optimization 
Results
The clinical data observed during CABG surgery are obtained as follows. The variations in MAP and CO with changes in noradrenaline and nitroglycerine infusions are shown in Figures 4-6. The maximum allowable limit for noradrenaline infusion is 0.01-3 µg/kg and nitroglycerine infusion is 0.01-1.5 µg/kg. The optimal values for PI controller were obtained and applied in patient model to simulate the controlled responses. Figure 7 shows the controlled MAP and CO with infusion of noradrenaline and nitroglycerine. The infusion rates of noradrenaline and nitroglycerine are shown in Figure 8 . The controller sensitivity was tested by introducing a disturbance at 500 s for MAP and CO. Since the MAP is influenced by nitroglycerine infusion, MAP is in decreasing manner from 150 mmHg to desired MAP of 93 mmHg and CO is influenced by infusion of noradrenaline hence the blood flow is in increasing manner from 3300 ml to 5000 ml. The controlled infusion rate of nitroglycerine is 0.02 µg/kg and that of noradrenaline is 0.1 µg/kg.
Discussion
The robustness of the controller is verified by considering an abnormality in the cardiovascular-baroreceptor The efficiency and performance of the controller is determined using time domain analysis as tabulated in Table 1 .
Conclusions
Infusion of multiple drugs creates a significant amount of complexity in the modeling process due to interaction of drugs. The future work focuses on study about interaction of drugs from clinical data and developing switching-based controllers for the efficient drug administration. Furthermore, the developed model and their respective controller which provides control action on cardiac drugs and anesthetic agent should be evaluated in the clinical setting to guarantee the total reliability of the controllers developed. The clinical data collected from this clinical evaluation can also be utilized in fine-tuning of the controllers.
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